Kintor Pharmaceutical Pink Sheet Forecast - Simple Exponential Smoothing
| KNTPF Stock | USD 0.35 0.02 6.06% |
Kintor Pink Sheet outlook is based on your current time horizon. We recommend always using this module together with an analysis of Kintor Pharmaceutical's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 27th of January 2026 The relative strength index (RSI) of Kintor Pharmaceutical's share price is above 80 . This indicates that the pink sheet is significantly overbought by investors. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 89
Buy Peaked
Oversold | Overbought |
Using Kintor Pharmaceutical hype-based prediction, you can estimate the value of Kintor Pharmaceutical Limited from the perspective of Kintor Pharmaceutical response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Exponential Smoothing forecasted value of Kintor Pharmaceutical Limited on the next trading day is expected to be 0.35 with a mean absolute deviation of 0 and the sum of the absolute errors of 0.18. Kintor Pharmaceutical after-hype prediction price | USD 0.35 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Kintor |
Kintor Pharmaceutical Additional Predictive Modules
Most predictive techniques to examine Kintor price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Kintor using various technical indicators. When you analyze Kintor charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Kintor Pharmaceutical Simple Exponential Smoothing Price Forecast For the 28th of January
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Kintor Pharmaceutical Limited on the next trading day is expected to be 0.35 with a mean absolute deviation of 0, mean absolute percentage error of 0.0002, and the sum of the absolute errors of 0.18.Please note that although there have been many attempts to predict Kintor Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Kintor Pharmaceutical's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Kintor Pharmaceutical Pink Sheet Forecast Pattern
| Backtest Kintor Pharmaceutical | Kintor Pharmaceutical Price Prediction | Buy or Sell Advice |
Kintor Pharmaceutical Forecasted Value
In the context of forecasting Kintor Pharmaceutical's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Kintor Pharmaceutical's downside and upside margins for the forecasting period are 0 and 5.14, respectively. We have considered Kintor Pharmaceutical's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Kintor Pharmaceutical pink sheet data series using in forecasting. Note that when a statistical model is used to represent Kintor Pharmaceutical pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 107.4677 |
| Bias | Arithmetic mean of the errors | -0.0013 |
| MAD | Mean absolute deviation | 0.003 |
| MAPE | Mean absolute percentage error | 0.0108 |
| SAE | Sum of the absolute errors | 0.18 |
Predictive Modules for Kintor Pharmaceutical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Kintor Pharmaceutical. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Kintor Pharmaceutical After-Hype Price Density Analysis
As far as predicting the price of Kintor Pharmaceutical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Kintor Pharmaceutical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Kintor Pharmaceutical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Kintor Pharmaceutical Estimiated After-Hype Price Volatility
In the context of predicting Kintor Pharmaceutical's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Kintor Pharmaceutical's historical news coverage. Kintor Pharmaceutical's after-hype downside and upside margins for the prediction period are 0.02 and 5.11, respectively. We have considered Kintor Pharmaceutical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Kintor Pharmaceutical is out of control at this time. Analysis and calculation of next after-hype price of Kintor Pharmaceutical is based on 3 months time horizon.
Kintor Pharmaceutical Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Kintor Pharmaceutical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Kintor Pharmaceutical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Kintor Pharmaceutical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.52 | 4.79 | 0.00 | 0.01 | 0 Events / Month | 1 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.35 | 0.35 | 0.00 |
|
Kintor Pharmaceutical Hype Timeline
Kintor Pharmaceutical is now traded for 0.35. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.01. Kintor is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is now at 0.52%. %. The volatility of related hype on Kintor Pharmaceutical is about 43545.45%, with the expected price after the next announcement by competition of 0.34. About 32.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.35. Kintor Pharmaceutical had not issued any dividends in recent years. Assuming the 90 days horizon the next projected press release will be uncertain. Check out Historical Fundamental Analysis of Kintor Pharmaceutical to cross-verify your projections.Kintor Pharmaceutical Related Hype Analysis
Having access to credible news sources related to Kintor Pharmaceutical's direct competition is more important than ever and may enhance your ability to predict Kintor Pharmaceutical's future price movements. Getting to know how Kintor Pharmaceutical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Kintor Pharmaceutical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PBIGF | Paradigm Biopharmaceuticals Limited | 0.00 | 0 per month | 0.00 | (0.07) | 15.38 | (13.33) | 37.57 | |
| POLBF | Poolbeg Pharma PLC | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| AURX | Nuo Therapeutics | 0.00 | 0 per month | 0.00 | (0.11) | 7.50 | (8.26) | 34.26 | |
| HOFBF | Hofseth BioCare ASA | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| IUGNF | Imugene Limited | 0.00 | 0 per month | 6.30 | 0.05 | 25.00 | (13.04) | 47.15 | |
| MSCLF | Satellos Bioscience | 0.00 | 0 per month | 3.10 | 0.18 | 10.42 | (5.88) | 19.61 | |
| SCNLF | Scancell Holdings plc | 0.00 | 0 per month | 0.00 | 0.02 | 0.00 | 0.00 | 16.67 | |
| SHIEF | Shield Therapeutics plc | 0.00 | 0 per month | 0.00 | 0.11 | 0.82 | 0.00 | 61.79 | |
| VSBC | VitaSpring Biomedical Co | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| IPHYF | Innate Pharma | (0.11) | 8 per month | 0.00 | 0.03 | 0.00 | 0.00 | 12.57 |
Other Forecasting Options for Kintor Pharmaceutical
For every potential investor in Kintor, whether a beginner or expert, Kintor Pharmaceutical's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Kintor Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Kintor. Basic forecasting techniques help filter out the noise by identifying Kintor Pharmaceutical's price trends.Kintor Pharmaceutical Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Kintor Pharmaceutical pink sheet to make a market-neutral strategy. Peer analysis of Kintor Pharmaceutical could also be used in its relative valuation, which is a method of valuing Kintor Pharmaceutical by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Kintor Pharmaceutical Market Strength Events
Market strength indicators help investors to evaluate how Kintor Pharmaceutical pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Kintor Pharmaceutical shares will generate the highest return on investment. By undertsting and applying Kintor Pharmaceutical pink sheet market strength indicators, traders can identify Kintor Pharmaceutical Limited entry and exit signals to maximize returns.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.06 | |||
| Day Median Price | 0.35 | |||
| Day Typical Price | 0.35 | |||
| Price Action Indicator | 0.01 | |||
| Period Momentum Indicator | 0.02 | |||
| Relative Strength Index | 89.03 |
Kintor Pharmaceutical Risk Indicators
The analysis of Kintor Pharmaceutical's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Kintor Pharmaceutical's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting kintor pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.51 | |||
| Standard Deviation | 4.68 | |||
| Variance | 21.94 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Kintor Pharmaceutical
The number of cover stories for Kintor Pharmaceutical depends on current market conditions and Kintor Pharmaceutical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Kintor Pharmaceutical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Kintor Pharmaceutical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Other Information on Investing in Kintor Pink Sheet
Kintor Pharmaceutical financial ratios help investors to determine whether Kintor Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kintor with respect to the benefits of owning Kintor Pharmaceutical security.